Fundraising Fox

Amplifyer Bio

Lexington, US · Founded 2023 · Delaware corporation · 10 employees on LinkedIn · 1 known investors

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

Founders & leadership

AMAnnie Murphy
Annie Murphyin
EK
Eric K. HuangNamed on SEC filing
JC
J. Christopher LoveNamed on SEC filing
VA
Viktor A. AdalsteinssonNamed on SEC filing

Board

TDThomas de Vlaam
Thomas de Vlaamin𝕏Board directorPartner at Pillar VC
SLStanley Lapidus
Stanley LapidusBoard directorCEO, SynapDX & Founding Pillar at Pillar VC

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7.1M disclosed across 1 round · 2024

$7.1MraisedOct 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric K. HuangExecutive Officer, Director
  • J. Christopher LoveDirector
  • Thomas de VlaamDirector
  • Viktor A. AdalsteinssonDirector
  • Stanley LapidusDirector
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Amplifyer Bio do?
Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.
Who are Amplifyer Bio's investors?
Amplifyer Bio's investors include Pillar VC.
How much funding has Amplifyer Bio raised?
Amplifyer Bio has disclosed $7.1M raised across 1 round.
Where is Amplifyer Bio headquartered?
Amplifyer Bio is headquartered in Lexington, US.